‘Means to an end’ – This startup co-founder is happier post-acquisition

Sarepta_Columbus_researcher-in-lab via sarepta.com

Louise Rodino-Klapac became a successful entrepreneur – but she’s a scientist first.

The Columbus-based executive vice president and chief scientific officer of Sarepta Therapeutics Inc. joined the Boston-area biotech in 2018 from Nationwide Children’s Hospital. Then Sarepta acquired the startup she’d cofounded.

Click here to read the complete story.

Story excerpt provided by Columbus Business First.

Written by Carrie Ghose.

Originally published October 7, 2021.

1 Comment on ‘Means to an end’ – This startup co-founder is happier post-acquisition

  1. Everything is very open with a clear explanation of the challenges.
    Great post RRB Group D Result

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: